GE Medical Systems Information Technologies, Inc.

GE Medical Systems Information Technologies, Inc., doing business as GE and operating as a subsidiary of General Electric Company, is the prime contractor on a large portfolio of federal medical equipment procurements and service contracts, competing exclusively in full-and-open markets without set-aside protections. The company supplies patient monitoring systems, cardiac diagnostic equipment, imaging systems, clinical software platforms, and associated maintenance and support services to the Department of Veterans Affairs, Defense Logistics Agency, Defense Health Agency, Indian Health Service, National Institutes of Health, and federal correctional facilities.

GE Medical Systems' federal footprint is dominated by a single dominant parent vehicle: the $300 million Federal Supply Schedule contract (FSS-65-II-A) for Medical Equipment and Supplies, awarded by the Department of Veterans Affairs Veterans Integrated Service Network 12 on June 1, 2021, and running through May 2026. This IDIQ carries 812 task orders with $123.4 million in combined potential value and serves as the underpin for the vast majority of GE's recent federal medical equipment procurement activity. Across the broader portfolio, 5,461 task orders are placed under the Federal Supply Schedule V797P4158A (a predecessor or related vehicle) with $265.9 million combined potential value. Representative delivery orders from the FSS-65-II-A include a $10.4 million physiological monitoring system for the Defense Health Agency (August 2025), a $1.44 million patient monitoring system also for the Defense Health Agency (September 2025), a $779,955 MUSE software licensing and support contract with Veterans Integrated Service Network 4 (February 2026, sole-source), a $506,230 MACLAB and COMBOLAB annual maintenance order with Veterans Integrated Service Network 4 (February 2024), and a $443,684 PMI MACLAB and COMBOLAB systems contract with Veterans Integrated Service Network 22 (July 2024). Numerous smaller delivery orders for CARESCAPE patient monitoring bundles, MACVU360 cardiac diagnostic equipment, blood-pressure cuffs, and medical supply consumables flow continuously through the Schedule to the Defense Logistics Agency Medical Supply Chain and individual VA facilities.

Customer concentration is extreme. The Defense Logistics Agency Troop Support Medical accounts for 1,648 awards with $671.6 million combined potential value—far more than any other customer by count—but the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 anchors the largest single dollar concentration at $914 million across 183 awards. Together, these two customers represent approximately 23% of GE's combined potential-value portfolio. The VA as an institution (summing all VISNs and components) is the dominant customer by far, with over 681 prime awards. The Department of the Navy Bureau of Medicine and Surgery ($13.9 million across 401 awards) and individual VA service networks round out the top tier. Federal agency concentration is broad—117 distinct customer agencies are served—but heavily skewed toward VA and defense medical procurement.

Award activity has declined in recent years. The vendor received 140 awards in 2022, dropping to 114 in 2023, 79 in 2024, and 81 in 2025; only 15 awards are recorded in 2026 through May. The combined potential value of the entire portfolio stands at $7.09 billion, but only $705.2 million (10%) has been obligated to date, reflecting the IDIQ structure's ceiling-based accounting. The recompete cliff within the next twenty-four months involves 32 awards with $7.7 million combined potential value—modest relative to portfolio size but concentrated in contract vehicles reaching expiration (particularly the FSS-65-II-A running through May 2026).

GE's capability footprint, grounded in the award record, centers on medical equipment manufacturing and distribution (NAICS 339112, Surgical and Medical Instrument Manufacturing carries 6,586 awards) and merchant wholesaling of medical equipment and supplies (NAICS 423450 accounts for 1,481 awards). The company delivers patient bedside monitoring systems (CARESCAPE B450, B650, B450 series), cardiac diagnostic and electrocardiograph platforms (MACVU360, MAC 5 LITE, CardioDay HOLTER systems, MUSE), laboratory analysis systems (MACLAB, COMBOLAB, ALTIX-MACLAB), telemetry and vital-sign monitoring (blood-pressure cuffs, oxygen saturation sensors, temperature monitors, infusion systems), anesthesia equipment maintenance (Datex-Ohmeda equipment), imaging equipment repairs (X-ray machines), and associated software upgrades and maintenance services. The company also performs OEM-level preventative and corrective maintenance, field service engineer response, 24/7 remote technical support with defined response times, on-site installation, configuration, and staff training. A $779,955 MUSE maintenance contract specifies one-hour remote response and four-hour critical-error resolution; a $410,570 MacLab maintenance contract guarantees six-hour response for disabled systems and 24-hour response for non-critical failures; a $297,030 anesthesia equipment maintenance contract covers preventive and corrective service, trace gas testing, and vaporizer efficacy testing across multiple units.

Service Contract Inventory activity is minimal and non-revenue-bearing. Across 11 SCI records (10 as prime, 1 as named subcontractor) spanning FY2022–FY2024, GE Medical Systems reported $0 in invoiced revenue and roughly 0.1 FTEs in FY2024. This reflects the fact that GE's federal business is almost entirely goods-based (medical devices, equipment, supplies) and maintenance services under fixed-price delivery orders and purchase orders, not labor-based professional services subject to SCI reporting thresholds.

GE Medical Systems operates as a 100% prime contractor (16,125 of 16,127 awards are prime; only 2 are subcontractor records, likely data artifacts). The company does not appear in the subcontractor footprint; it is a direct prime to federal agencies and does not serve as a feeder for larger system integrators. Named subsidiary Datex-Ohmeda, Inc. (also a GE subsidiary) appears in the corporate structure block and likely represents anesthesia and perioperative monitoring equipment—capabilities reinforced by the anesthesia equipment maintenance contracts in the award record.

GE Medical Systems' grant footprint is limited to a single cooperative agreement: "In Vivo Imaging of Glymphatic Circulation: Measurement of Brain Interstitial Fluid Flow During Wake and Sleep with Ultra-High Performance MRI," awarded by the Defense Health Agency on August 15, 2022, with ultimate completion extended to August 14, 2027 (at no additional cost). GE serves as the prime recipient, contributing protamine-conjugated bead and swab development, macromolecular analysis expertise, and collaboration on experimental design and manuscript preparation in support of West Virginia University Research Corporation's forensics and neuroscience research.

GE Medical Systems Information Technologies, Inc. headquarters are in Wauwatosa, Wisconsin, where the company maintains its primary manufacturing and distribution facilities, though work is performed at customer sites across the continental United States, Hawaii, and veteran healthcare facilities nationwide. As a large, established federal contractor with continuous SAM.gov registration since May 2001, GE competes entirely in full-and-open procurements without set-aside restrictions, reflecting its designation as a large business capable of competing on price, capability, and OEM expertise across the federal medical equipment marketplace.